Dezima Initiates Phase 2b TULIP Study on CETP Inhibitor Program DEZ-001

News   Aug 30, 2013

 
Dezima Initiates Phase 2b TULIP Study on CETP Inhibitor Program DEZ-001
 
 
 

RELATED ARTICLES

Protein's Role in Mitochondrial Metabolism Identified

News

EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.

READ MORE

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

News

Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.

READ MORE

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE